I've tried to find a way to use regsho, shortanalytics and various brokerage reporting of shares available to short to determine what the short community is doing real time with a stock. Pretty unsuccessful on the whole. No correlation I've found to show what is being sold vs covered. It seems like shortanalytics is useful in showing what pct of volume is coming from short activity vs long, but isn't a directional tool. I've tried sending them emails to help me understand how to use the data but no responses.
This looks pretty interesting now. At first glance the offering is pegging the price at around $2.59:
$12m for Preferred D
$18.175m for conversion at $3.12
Total proceeds $30.175m
Common shs to be issued upon conversion 5.825m x 2 or 11.65m
Summary: premarket price below the level institutions are buying and should support. Price is below price where it spiked on news. Looks like a good entry point to me
But is Van a dual threat guy? Wilson's AA option was just bought by the Texas Rangers in case he ever decides to give professional baseball a shot....primarily because of his leadership and competitive skills. Definitely a nice combination when looking at SQNM next leaders.
Pru-Didn't realize until Allen posted that you are still unable to get on other board with this ID. I sent Rtheis and email last night so hope that gets fixed
I just uploaded my model on the site. Take a look at the tabs DiagAge, DiagCust and DiagProd. They are all charts showing the component of diagnostic revenues reported by major customer, region, product and in quarter vs old billings. Easy to play with the assumptions and see how it trends out. The range of possible outcomes this quarter is quite large. Start a topic on other board if you want to chat.
While I wish they had something fresh to say, gotta agree the presentation was crisp.
Let's hope for some good news soon! Possibles:
- GA sale/partnership with big player.
- New National payor signed.
- MolDX codes established with positive reimbursement amount
Absent one of these we wait for Q4 release. Possible wild card:
Since this is year end for most insurance companies they will need to work hard to finalize their liabilities for tests and claims processed for their auditors. Is it possible they will piggy back that effort and agree to pay some of these back billings to clean up their liabilities?
Take a look at a 2-3wk chart of LH, DGX and SQNM. The correlation is pretty clear.
Easy answer. Is the budget deal going to impact Q4 reimbursements?
For one of the few times, I agree with you. This is not a bear raid nor is it a short driven sell off. These are long investors heading for the doors because of concerns about reimbursements and cash flows. I also agree with the metaphor about security sucking. They set this table by not preannouncing the Jun miss. With that precedent, no one trusts this team to get out in front of bad news. So sell first and ask questions later.
Call it what you want. The NIPT business is NOT what caused the soft guidance, price target cuts and and downgrades. The insurance issues caused by Affordable Care Act is what they pointed to which is impacting health care companies across the board. Guess what, SQNM has to have insurance reimbursement to recognize revenues. So this issue is magnified exponentially for them. Chicken sh$t or not is your call.
LabCorp sees its price targets cut after delivering weak guidance • 10:32 AM
• Analysts are beginning to weigh in on shares of Laboratory Corporation of America (LH -9.1%) after the company's guidance disappointed investors on Tuesday evening.
• Canaccord has cut the shares to Hold from Buy. Price target slashed to $91 from $115.
• Credit Suisse takes its price target to $92 from $104.
The Jun-13 quarter miss is haunting them now. The market has no idea if they are having a soft quarter or not. WIth LH coming out with soft guidance on Affordable Care Act issues and utilization issues, we are assumed to have the same issues.
LoL glad you find it entertaining. I don't recall saying it would go up in 3 weeks in the midst LH and DGX downgrades, court awards and guidance cuts but clearly I don't have your perceptive ability to read into what was written. Nothing in the article has changed but as always it's one persons perspective. Keep living your dream of contributing nothing and looking for opportunities to bash anyone who tries to. Must be working for you considering how much effort you put into it.
It appears you think that your repeated prods are having some impact. I learned long ago to feel sorry for you rather than be a hater. Hope you find something to make your life worthwhile. I'll leave it at that since you have again found nothing of substance to discuss.
Glad to hear you enjoy the Seahawks. They are a great contrast to the Bears. Bears tried to stick with vets for too long on Defense which now is killing them. Thin roster with an old style deep cover 2 scheme that is tough in todays game. Focus on offense is finally paying off but you don't go anywhere without defense.,
Seahawks focused on youth, building from line out with a focus on man up defense with d backs. The last thing they invested in were the wideouts on offense which worked with the core they had. Run the ball. Stop the run., Stop the pass and then build a pass offense. Only team I've seen that can withstand the number of players lost and still be so dominant. 2 offensive line starters gone for several weeks didn't matter. 2 best pass rushers lost for weeks didn't matter. 2 key defensive backs lost doesn't matter. top 2 wide receivers lost for weeks doesn't matter. Amazing and very young. Only thing that will change their competitive trajectory over next few years is free agency as these guys all have contracts that are relatively cheap and will expire in a couple years.
Hey bud-glad the bears offense was hot as their defense isn't much better than the Cowboys. Hard to watch a bears team get shredded with an opponents run game. Seahawks are fun this year and have a chance to go a long way if they stay healthy. Enjoy your holidays.
So your only comment about anything in my post was that the article
did not seem too bad
we are down over 15%
You "retired" ...2007
you did not agree with HH
Since you chose to again provide no substance. I guess I'll have to follow up, given your propensity to reference me on a board I rarely even visit.
If my article "did not seem too bad" why would you continue to reference it with smirking references to the stock performance? GIven your attempts to correlate this article with stock performance, are you also suggesting my article led to the 6% declines in LabCorp and Quest? Or did my article really prompt he BoA analyst today to downgrade Quest because performance concerns? I had no idea a simple article could have that type of impact.
Next time I write an article, let's agree that I'll give you advanced notice so you can short the stock and benefit.
Since you have specifics where we apparently disagree on HH moves, please provide these as topics to be included in the article.
I noticed that you have referenced my article several more times since I last visited this board. Since you appear to be so fixated with it, please let me know what questions or concerns you have with it and I'll be happy to reply.
Also would appreciate hearing your take of the short interest reported was posted last night. Nice having advance notice.
Finally, please provide any trading tips learned from your stint at RBCCMC until Jun-09, and how that led to your buy/hold/whine strategy used with SQNM. Has proven very effective so I'm sure many could learn from the dialog.
Also interesting to note that the starmine ranking of relative accuracy is as follows for WYY:
Thompson Reuters 44
The StarMine Relative Accuracy Score for each research provider uses the past performance of the provider's individual stock recommendations with that of its peers in each sector to calculate a statistical aggregation ranging from 1 to 100.